High-throughput sequencing of chromatin regulatory elements

染色质调控元件的高通量测序

基本信息

项目摘要

DESCRIPTION (provided by applicant): A key goal in characterizing the human genome is to acquire a complete catalog of chromatin regulatory elements and sequence determinants of chromatin state. In this application, we propose to undertake a large-scale project to map the genomewide locations of >35 histone modifications and related proteins in >20 human cell types by coupling chromatin IP with massive-throughput sequencing on the Solexa platform. Our preliminary data demonstrate that this approach is highly accurate and a major advance over existing technologies in terms of cell requirements, genome coverage, throughput and cost-effectiveness. A sequencing pipeline will be applied to generate more than 500 genomewide datasets of chromatin structure by sequencing >1000 samples. A computational pipeline will then convert the sequencing reads into high resolution, genomewide maps that can be visualized in genome browsers and used for downstream analysis. Comparative genomic analysis and motif-finding tools will be applied to classify genomic sites based on associated chromatin structures and to identify underlying sequence determinants. Cell and molecular biology methods will be used to validate inferred functions for a representative subset of discovered elements. Chromatin regulation is extensively implicated in many aspects of human development and disease. In particular, cancer cells may universally exhibit aberrant chromatin states. The proposed systematic identification and characterization of chromatin regulatory elements in the human genome will offer unprecedented insight into the structure and function of chromatin, and provide an invaluable resource for investigators in chromatin, genomics, cancer and many other fields of research. All data collected in the context of the proposed project will be made available pre-publication to the greater scientific community once reliability has been confirmed.
描述(由申请人提供):表征人类基因组的一个关键目标是获得染色质调控元件和染色质状态序列决定因素的完整目录。在本申请中,我们建议在Solexa平台上进行一项大规模的项目,通过将染色质IP与大通量测序相结合,绘制>20种人类细胞类型中>35组蛋白修饰和相关蛋白的全基因组位置。我们的初步数据表明,这种方法是高度准确的,并且在细胞需求,基因组覆盖,吞吐量和成本效益方面比现有技术有了重大进步。测序流水线将通过测序1000个样本,生成500多个全基因组染色质结构数据集。然后,计算管道将把测序读数转换成高分辨率的全基因组图谱,这些图谱可以在基因组浏览器中可视化,并用于下游分析。比较基因组分析和基序寻找工具将应用于基于相关染色质结构的基因组位点分类,并确定潜在的序列决定因素。细胞和分子生物学方法将用于验证已发现元素的代表性子集的推断功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(5)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRADLEY Evan BERNSTEIN其他文献

BRADLEY Evan BERNSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRADLEY Evan BERNSTEIN', 18)}}的其他基金

Single molecule detection of L1 insertions and intermediates
L1 插入和中间体的单分子检测
  • 批准号:
    10662586
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
A Foundational Resource of Functional Elements, TF footprints and Gene Regulatory Interactions
功能元件、转录因子足迹和基因调控相互作用的基础资源
  • 批准号:
    10296063
  • 财政年份:
    2021
  • 资助金额:
    $ 135.05万
  • 项目类别:
A Foundational Resource of Functional Elements, TF footprints and Gene Regulatory Interactions
功能元件、转录因子足迹和基因调控相互作用的基础资源
  • 批准号:
    10640985
  • 财政年份:
    2021
  • 资助金额:
    $ 135.05万
  • 项目类别:
A Catalog of Cell Types and Genomic Elements in Tissues, Organoids and Disease
组织、类器官和疾病中的细胞类型和基因组元件目录
  • 批准号:
    9810980
  • 财政年份:
    2017
  • 资助金额:
    $ 135.05万
  • 项目类别:
A Catalog of Cell Types and Genomic Elements in Tissues, Organoids and Disease
组织、类器官和疾病中的细胞类型和基因组元件目录
  • 批准号:
    10240019
  • 财政年份:
    2017
  • 资助金额:
    $ 135.05万
  • 项目类别:
A Catalog of Cell Types and Genomic Elements in Tissues, Organoids and Disease
组织、类器官和疾病中的细胞类型和基因组元件目录
  • 批准号:
    9247265
  • 财政年份:
    2017
  • 资助金额:
    $ 135.05万
  • 项目类别:
Single-molecule systems for decoding combinatorial chromatin modifications
用于解码组合染色质修饰的单分子系统
  • 批准号:
    9360134
  • 财政年份:
    2016
  • 资助金额:
    $ 135.05万
  • 项目类别:
Epigenetic plasticity in tumor initiation and evolution
肿瘤发生和进化中的表观遗传可塑性
  • 批准号:
    9162565
  • 财政年份:
    2016
  • 资助金额:
    $ 135.05万
  • 项目类别:
Epigenetic plasticity in tumor initiation and evolution
肿瘤发生和进化中的表观遗传可塑性
  • 批准号:
    10441748
  • 财政年份:
    2016
  • 资助金额:
    $ 135.05万
  • 项目类别:
Epigenetic plasticity in tumor initiation and evolution
肿瘤发生和进化中的表观遗传可塑性
  • 批准号:
    9750074
  • 财政年份:
    2016
  • 资助金额:
    $ 135.05万
  • 项目类别:

相似国自然基金

围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
  • 批准号:
    489995
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
    Operating Grants
The role of protein arginine methyl transferase PRMT1 on myelin development
蛋白精氨酸甲基转移酶PRMT1对髓磷脂发育的作用
  • 批准号:
    23K14287
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
使用 Sepiaptein 使精氨酸代谢正常化以实现 HER2 乳腺癌的免疫刺激转变
  • 批准号:
    10776256
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
精氨酸消耗联合铂类紫杉烷化疗对侵袭性变异前列腺癌 (AVPC) 的影响
  • 批准号:
    10715329
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
Physiological function of arginine signaling:macropinocytosisand tumor immune evasion
精氨酸信号的生理功能:巨胞饮作用与肿瘤免疫逃避
  • 批准号:
    23H03317
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
  • 批准号:
    498862
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
    Operating Grants
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
  • 批准号:
    10584689
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
Arginine methylation of the RNA helicase DDX5 in the regulation of RNA/DNA hybrids during the DNA damage response.
RNA 解旋酶 DDX5 的精氨酸甲基化在 DNA 损伤反应期间调节 RNA/DNA 杂交体中的作用。
  • 批准号:
    487619
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
    Operating Grants
Regulation of and Target Recognition by Protein Arginine Methyltransferase 1 (PRMT1)
蛋白质精氨酸甲基转移酶 1 (PRMT1) 的调节和目标识别
  • 批准号:
    10653465
  • 财政年份:
    2023
  • 资助金额:
    $ 135.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了